Herpetic Anterior Uveitis Multicentre Longitudinal Study (The UVHER Project). Baseline Characteristics.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 7 9 2023
pubmed: 2 8 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

The aim of the UVHER project is to evaluate the risk of development of optic nerve damage in patients with herpetic anterior uveitis (AU) prospectively followed over 2 years. Herein, we described the baseline characteristics. This is a multicentre, prospective study. An aqueous humour tap was performed. Only patients with a positive PCR were included. Clinical characteristics, optical coherence tomography (OCT) parameters and visual field (VF) abnormalities were registered. 27 patients were included: 18 Herpes Simplex (HSV), one Varicella Zoster (VVZ), and 8Cytomegalovirus (CMV). Patients with HSV-AU had severe inflammation, iris atrophy and corneal involvement. In patients with CMV-AU, less inflammation and medium-to-large keratic precipitates were observed. OCT showed a thinner RNFL and GCL in CMV-AU patients in comparison to HSV patients. VF showed abnormalities in six cases. Patients in the UVHER cohort showed the typical clinical manifestations of herpetic AU. In CMV patients, optic nerve damage was observed at baseline, and in HSV patients, inflammation was more severe.

Identifiants

pubmed: 35914310
doi: 10.1080/09273948.2022.2103829
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1497-1504

Auteurs

Sonia Valsero Franco (S)

Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.

Carolina Bernal-Morales (C)

Department of Ophthalmology, Clinic Hospital, Barcelona, Spain.

Borja Santos Zorrozua (B)

Department of Biostatistics, BioCruces Health Research Institute, Bilbao, Spain.

Maitane Aranzamendi Zalmumbide (M)

Department of Microbiology, Cruces University Hospital, Bilbao, Spain.

Joseba Artaraz Beobide (J)

Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.

Maite Sainz-de-la-Maza (M)

Department of Ophthalmology, Clinic Hospital, Barcelona, Spain.

Victor Llorenç (V)

Department of Ophthalmology, Clinic Hospital, Barcelona, Spain.

Alfredo Adan (A)

Department of Ophthalmology, Clinic Hospital, Barcelona, Spain.

Alex Fonollosa (A)

Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
Department of Retina, Instituto Oftalmológico Bilbao, Bilbao, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH